Volume 15, Issue 3 pp. 223-230
Article
Full Access

Comparison of western blot analysis to microneutralization for the detection of type-specific herpes simplex virus antibodies

David I. Bernstein

David I. Bernstein

Divisions of Pediatrics, Department of Microbiology and Immunology, UCLA Medical Center, Los Angeles, California

Search for more papers by this author
Eileen Garratty

Eileen Garratty

Divisions of Pediatrics, Department of Microbiology and Immunology, UCLA Medical Center, Los Angeles, California

Search for more papers by this author
Michael A. Lovett

Michael A. Lovett

Adult Infectious Diseases, Department of Microbiology and Immunology, UCLA Medical Center, Los Angeles, California

Search for more papers by this author
Yvonne J. Bryson MD

Corresponding Author

Yvonne J. Bryson MD

Divisions of Pediatrics, Department of Microbiology and Immunology, UCLA Medical Center, Los Angeles, California

Division of Pediatrics, UCLA School of Medicine, Los Angeles, CA 90024===Search for more papers by this author
First published: March 1985
Citations: 19

Abstract

A newly developed system (as described in the previous paper) employing separated herpes simplex virus (HSV) polypeptides electrophoretically transferred to nitrocellulose paper, Western Blot Analysis (WBA), was compared to microneutralization (MN) for the detection of type-specific antibody to HSV types 1 and 2 in 98 human sera. Sera containing HSV1-specific antibodies reacted at least twofold more densely (as quantitated by densitornetric scanning) to HSV1 than HSV2 polypeptides, while sera with HSVZspecific antibodies reacted twofold more densely to HSV2 polypeptides. The reliability of this system was determined (1) by analysis of sera from patients with true primary herpes simplex infections, (2) by adsorption studies that removed cross-reacting antibodies, and (3) by comparison with neutralization. Of 36 sera found to have HSVl-type-specific antibody by WBA, 83% had MN ratios of <85 (indicating HSVl antibody), while of 28 sera found to have HSV2-type-specific antibody by WBA, 89% had MN ratios of >85 (indicating HSV2 antibodies). The MN ratio obtained on sera felt to have both HSV1-type-specific and HSV2-type-specific antibody by WBA ranged from 67 to 160. WBA agreed more closely with clinical isolates and adsorption studies than MN. This system not only accurately determines the HSV-type-specific antibody status of patients but provides important information on the specific immunogenic proteins.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.